MCM
AVNS

Moore Capital Management’s Avanos Medical AVNS Stock Holding History

Moore Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.37M Sell
97,960
-3,925
-4% -$52.9K 0.03% 340
2025
Q4 		$1.14M Buy
101,885
+13,626
+15% +$156K 0.02% 438
2025
Q3 		$1.02M Buy
88,259
+34,812
+65% +$408K 0.01% 424
2025
Q2 		$654K Sell
53,447
-7,840
-13% -$98.6K 0.01% 411
2025
Q1 		$878K Buy
61,287
+24,217
+65% +$378K 0.02% 327
2024
Q4 		$590K Buy
+37,070
New +$734K 0.01% 412

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Moore Capital Management's AVNS Position: Q1 2026 in Review

Moore Capital Management reduced its Avanos Medical (AVNS) stake by 3.9% in Q1 2026, selling an estimated $52.9K and leaving 97,960 shares worth $1.37M. The position accounts for 0.03% of the portfolio, ranked #340.

Moore Capital Management first reported a position in AVNS in Q4 2024 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Moore Capital Management held 97,960 shares of Avanos Medical worth $1.37M as of Q1 2026.
  • Moore Capital Management sold 3,925 Avanos Medical shares in Q1 2026, an estimated $52.9K.
  • Avanos Medical made up 0.03% of Moore Capital Management's portfolio in Q1 2026, its #340 holding.
  • Moore Capital Management first reported a position in Avanos Medical in Q4 2024 and has held it in 6 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.